Trial Profile
Prospective randomised controlled trial comparing trigonal versus trigone-sparing intradetrusor injection of botulinum toxin-a for refractory idiopathic detrusor overactivity.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Apr 2011
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 15 Nov 2010 Actual end date (15 Nov 2010) added as reported by ISRCTN: Current Controlled Trials.
- 15 Nov 2010 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
- 09 Oct 2010 New trial record